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Background: Though a low carbohydrate (CHO) diet is effective for weight loss, concern remains that low CHO diets may increase cardiac risk due 
to higher fat intake. We hypothesized that a low CHO diet would be as effective as a low fat diet for ameliorating metabolic syndrome (MetSyn).
Methods: Obese or overweight but otherwise healthy subjects (n=77), aged 40-65 years (mean (SD) 48.5 ± 9.1 years) were randomized to 
6-months of an isocaloric low-CHO or low fat diet, each combined with supervised exercise training. Measurements included anthropometrics, lipid 
profile, serum glucose, and BP.
Results: Sixty subjects completed the study. At baseline, subjects had 1.9 ± 1.0 indices of MetSyn; 23.3% of subjects met full criteria. Mean 
weight was 98.6 ± 15.4 kg, waist circumference 102.6 ± 10.8 cm, fasting glucose 92.7 ± 9.2 mg/dL, triglycerides 117.9 ± 66.6 mg/dL, HDL 52.8 
± 15.9 mg/dL, and BP 125 ± 14 / 74 ± 9.8 mmHg with no differences between groups. At 6 months, the low-CHO v. the low-fat group had a greater 
reduction in weight (-13.1 ± 6.0 v. -8.2 ± 4.7 kg), waist circumference (-12.1 ± 6.0 v. -6.1 ± 7.8 cm) and triglycerides ( -49.1 ± 52.7 v. -7.4 ± 49.8 
mg/dL) and increase in HDL (+8.1 ± 13.6 v. +0.8 ± 13.3 mg/dL), with p < 0.05 for all comparisons. Both groups demonstrated similar reductions 
in glucose, -5.7 ± 11.0 mg/dL, and BP, -10 ± 12.1 / -8.6 ± 8.2 mmHg, both p<0.05. At 6 months, subjects had 1.2 ± 1.0 indices of MetSyn, p < 
.001 for change from baseline; 10% of subjects met full criteria, p < 0.05 for change from baseline with no difference between groups. In regression 
analyses, the decrease in number of MetSyn indices was associated with the magnitude of weight loss independent of the diet followed.
Conclusion: Both weight loss programs improved indices of MetSyn, independent of the macronutrient content of the diet. These results suggest 
that a low-CHO diet as part of a weight loss program is a viable option for reducing cardiovascular disease burden.
